Current strategies to prevent sexually transmitted infections (STIs) are not controlling the epidemic. The efficacy of doxycycline STI postexposure prophylaxis shows promise in pilot studies, but wider acceptability is unknown. A majority (84%) of diverse individuals using a gay social networking application were interested in doxycycline STI postexposure prophylaxis. Doxycycline STI postexposure prophylaxis should be examined in larger trials.
Sexually transmitted infections are increasing with new prevention options needed. Most MSM (84%) using a gay social networking application were interested in using doxycycline sexually transmitted infection prophylaxis.
From the *Division of HIV, ID, and Global Medicine, University of California, San Francisco;
†Bridge HIV, San Francisco Department of Public Health; and
‡Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA
Conflicts of Interest and Sources of Funding: This study was supported by the National Institute of Health (R01MH109320). The authors have no conflicts of interest to declare.
Correspondence: Matthew A. Spinelli, MD, Department of Epidemiology and Biostatistics, University of California, San Francisco, 25 Van Ness Avenue, Suite 100 San Francisco, CA 94102. E-mail: firstname.lastname@example.org.
Received for publication June 26, 2018, and accepted October 29, 2018.